Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here

Pricing and Ordering Information
ClearState

India Disease Incidence & Prevalence Report
Report #CS303IN -
April 2013


India Disease Incidence and Prevalence: A combination of infectious and chronic diseases are causing social and economic burdens

As the tenth largest economy in the world, India spends approximately 5% of its GDP on healthcare. The private sector plays a significant role in healthcare delivery and expenditures, while public health expenditures account for an estimated 1% of GDP. With a current population of 1.2 billion, India is expected to overtake China as the world's most populous country by 2030.

In India, there is a gradual transition from infectious to chronic diseases as the population grows older, richer and more urbanised. Sedentary lifestyles and increased consumption of high-fat foods such as fast food are contributing to the growing prevalence of chronic diseases like hypertension and diabetes. Diet is an important factor in certain diseases in India; for example, low dietary intake contributes to iron-deficiency or anaemia, while a diet high in certain spices like curcumin may help prevent colon cancer. In 2011, anaemia was the most prevalent disease in India, followed by hypercholesterolemia (high cholesterol). It is estimated that there are almost 224 million people with high cholesterol in India. Osteoporosis is the third most prevalent disease in India, with 165 million people afflicted with the condition.

Despite improvements, infectious diseases are still a major burden on the Indian healthcare system due to the lack of proper sanitation and health care provisions in certain parts of India; for example dysentery is still a common disease despite efforts to improve living conditions. Some state governments have begun efforts to improve healthcare in their states by allocating a larger proportion of their budgets towards healthcare and offering highly subsidized medical consultation to those who are under the poverty line. Currently 37% of India's total population falls into this group and a large proportion of rural residents still rely on alternative forms of medical treatment like acupuncture, ayurvedic medicine and unani.

Ordering Information

Title

Report# Publication
Date
List Price

India Disease Incidence & Prevalence Report

CS303IN

April 2013

$5,950

Order Online:
Single User only (Please call for corporate subscription pricing)
    PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

METHODOLOGY STATEMENT

INTRODUCTION

 

1. INDIA HEALTHCARE OVERVIEW

1.1 Macroeconomic Overview

1.2 Social and Demographic Factors

1.3 Healthcare System Challenges

1.4 Hospital Services

1.5 Medical Devices

 

Exhibit 1-1:      Key Economic and Health Statistics

Exhibit 1-2:      Percentage Distribution of Projected Population by Age Group in India, 2016-2026

Exhibit 1-3:      Selected Causes of Death in India

 

2. BLOOD DISORDERS

2.1 Anaemia

2.2 Haemophilia

 

Exhibit 2-1:      India, Prevalence of Blood Disorders

 

3. CANCER

3.1 Bladder Cancer

3.2 Brain Tumour

3.3 Breast Cancer

3.4 Cervical/Uterine Cancer

3.5 Colon/Rectal Cancer

3.6 Leukaemia

3.7 Lung Cancer

3.8 Lymphoma3.9 Melanoma

3.10 Oesophageal Cancer

3.11 Oral Cancer

3.12 Ovarian Cancer

3.13 Pancreatic Cancer

3.14 Prostate Cancer

3.15 Stomach Cancer

3.16 Testicular Cancer

 

Exhibit 3-1:      India, Incidence of Cancer

 

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia

4.2 Heart Failure

4.3 Heart Valve Disorders

4.4 Hypercholesterolemia

4.5 Hypertension

4.6 Vascular Disorders

 

Exhibit 4-1:      India, Prevalence of Cardiovascular Disorders

 

5. METABOLIC DISORDERS

5.1 Cholelithiasis and Cholecystitis

5.2 Chronic Kidney Disease / End-Stage Renal Disease

5.3 Diabetes

5.4 Urolithiasis

 

Exhibit 5-1:      India, Prevalence of Metabolic Disorders

 

6. MUSCULOSKELETAL DISORDERS

6.1 Arthritis

6.2 Carpal Tunnel Syndrome

6.3 Duchenne Muscular Dystrophy

6.4 Osteoporosis

 

Exhibit 6-1:      India, Prevalence of Musculoskeletal Disorders

 

7. NEUROLOGIC AND PSYCHIATRIC DISORDERS

7.1 Alzheimer’s Disease

7.2 Amyotrophic Lateral Sclerosis

7.3 Bipolar Disorder

7.4 Cerebrovascular Disease

7.5 Depression

7.6 Epilepsy

7.7 Huntington’s Disease

7.8 Multiple Sclerosis

7.9 Parkinson’s Disease

7.10 Schizophrenia

 

Exhibit 7-1:      India, Prevalence of Neurologic and Psychiatric Disorders

 

8. OPTHALMIC DISORDERS

8.1 Cataracts

8.2 Glaucoma

 

Exhibit 8-1:      India, Prevalence of Ophthalmic Disorders

 

9. REPRODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia

9.2 Endometriosis

9.3 Erectile Dysfunction

9.4 Infertility

9.5 Urinary Incontinence

 

Exhibit 9-1:      India, Prevalence of Reproductive and Genitourinary Disorders

 

10. RESPIRATORY DISORDERS

10.1 Adult Respiratory Distress Syndrome

10.2 Apnoea

10.3 Asthma

10.4 Chronic Obstructive Pulmonary Disease

10.5 Cystic Fibrosis

 

Exhibit 10-1:    India, Prevalence of Respiratory Disorders

 

11. WOUNDS

11.1 Diabetic Ulcer

11.2 Surgical Wounds

11.3 Traumatic Wounds

 

Exhibit 11-1:    India, Prevalence of Wounds

 

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Dysentery

12.2 Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome

12.3 Leprosy

12.4 Lymphatic Filariasis

12.5 Malaria

12.6 Measles

12.7 Pneumonia

12.8 Tuberculosis

 

Exhibit 12-1:    India, Incidence of Conditions Caused by Infectious Organisms

 

APPENDIX: REFERENCES

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.800.332.2181) or fax 1.908.748.1222.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home